`

Syntese, a Ferring Company

Pharmaceutical Manufacturing

Specialities :
Active pharmaceutical ingredient
Mesalazine
And mesalamine
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
51 - 200

Frequently Asked Questions About Syntese, a Ferring Company

What does Syntese, a ferring company do?+

Syntese A/S is a part of a Ferring Group and we are a word-leading manufacturer of 5-aminosalicylic acid - Mesalazine. It is an Active Pharmaceutical Ingredient used by the pharmaceutical industry in formulations for a treatment of Inflammatory Bowel Diseases (IBD) i.e. Ulcerative Colitis, Crohns Disease. Syntese has developed its own manufacturing method (chemical synthesis) of 5-ASA and implemented it for full-scale production in compliance with cGMP. Today Mesalazine is manufactured in multi-tons per year in the companys highly automated production facility in Hvidovre, industrial outskirts of Copenhagen. Having more than 30 years experience in product- and process development Syntese...

What are Syntese, a ferring company's specialties? +

Active pharmaceutical ingredient,mesalazine,and mesalamine

What is Syntese, a ferring company's industry? +

Syntese, a ferring company operates in the Pharmaceutical manufacturing industry.

What is Syntese, a ferring company's revenue? +

Syntese, a ferring company's revenue is 11m - 100m

What is Syntese, a ferring company's company size? +

Syntese, a ferring company has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.